Locations:
SearchA scannable recap of recent volumes and clinical metrics from Cleveland Clinic
Below we share recent volumes and clinical outcomes from two programs in Cleveland Clinic’s Heart, Vascular & Thoracic Institute: heart failure and recovery, and electrophysiology and cardiac pacing.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Heart transplants, including 2 pediatric cases
Left ventricular assist device (LVAD) implantations
Patients referred for heart transplant evaluation
| Time frame | Cleveland Clinic | U.S. benchmark |
|---|---|---|
| At 1 year | 97.6% | 92.2% |
| At 3 years | 89.8% | 85.0% |
| Time frame | ||
| At 1 year | ||
| Cleveland Clinic | ||
| 97.6% | ||
| U.S. benchmark | ||
| 92.2% | ||
| At 3 years | ||
| Cleveland Clinic | ||
| 89.8% | ||
| U.S. benchmark | ||
| 85.0% |
LVAD implants over the past 3 years, among the highest volumes in the U.S.
1-year post-implant survival, primary LVADs (vs. 85.2% STS Intermacs survival) (for period 4/1/24-9/30/25)
1-year post-implant survival, continuous-flow LVADs for destination therapy (vs. 84.7% STS Intermacs survival) (for period 4/1/24-9/30/25)
| Time frame | Cleveland Clinic | STS Intermacs |
|---|---|---|
| 12 months | 86.1% | 83.2% |
| 48 months | 62.0% | 56.7% |
| 60 months | 54.3% | 48.9% |
| Time frame | ||
| 12 months | ||
| Cleveland Clinic | ||
| 86.1% | ||
| STS Intermacs | ||
| 83.2% | ||
| 48 months | ||
| Cleveland Clinic | ||
| 62.0% | ||
| STS Intermacs | ||
| 56.7% | ||
| 60 months | ||
| Cleveland Clinic | ||
| 54.3% | ||
| STS Intermacs | ||
| 48.9% |
EP lab procedures, 2021-2025
EP lab procedures in 2025, highest annual total to date
Lead extraction procedures, 2021-2025
Clinical success rate for lead extractions
In-hospital mortality, vs. benchmark of 1.2% (Kusumoto et al., Heart Rhythm. 2017)
Atrial fibrillation ablations, 2021-2025
Major complication rate, vs. benchmark of 2.50% (Hsu et al., J Am Coll Cardiol. 2023)
Ventricular arrhythmia ablations, 2021-2025
Major complication rate, vs. benchmark of 10% (Cronin et al., Heart Rhythm. 2020)
LAAO devices implanted (includes both EP and interventional cases), 2021-2025
Major complication rate within 7 days of LAAO device implant, vs. benchmark of 2.7%-8.7% in published trials (Boersma et al., Eur Heart J. 2016)
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long tradition of reporting volume and outcomes data across subspecialty areas. For more information like the data above, visit clevelandclinic.org/e15.
Advertisement
Advertisement
Experts are challenging the one-size-fits-all paradigm
Decongestion, therapy titration and readmission rates comparable to those with traditional hospital care
Metabolites from animal product substrates implicated in heart failure development in community cohorts
Panel proposes staging and treatment protocols that support harmonized evaluation and management of heart failure in patients with congenital heart disease
Eminent clinician-researcher brings special expertise in nutritional interventions for heart failure
Recent volume and outcomes data in two major realms of cardiovascular care
Volatile organic compounds have potential in heart failure diagnostics
Basic understanding of condition and treatment is lacking